Evidence map›Paper›PMID 35780789›Full record

ArticleLancet (London, England)2022

Shifting gender barriers in immunisation in the COVID-19 pandemic response and beyond.

Tiffany Nassiri-Ansari, Phionah Atuhebwe, Akosua Sika Ayisi, Sarah Goulding, Mira Johri, Pascale Allotey, Nina Schwalbe

Open access · bronzeAbstract readLetter
In one paragraph

Article in Lancet (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 5 countries.

Tiffany Nassiri-AnsariInternational Institute for Global Health, United Nations University, Hospital Canselor Tuanku Muhriz UKM, Bandar Tun Razak, Cheras, Kuala Lumpur, Malaysia.
Phionah AtuhebweWHO Regional Office for Africa, Cité du Djoué, Brazzaville, Democratic Republic of the Congo.
Akosua Sika AyisiGreater Accra Regional Health Directorate, Ghana Health Service, Accra, Ghana.
Sarah GouldingDepartment of Foreign Affairs and Trade, Australian Federal Government, Barton, ACT, Australia.
Mira JohriDépartement de gestion, d'évaluation, et de politique de santé, École de santé publique de l'Université de Montréal, Montreal, Canada.
Pascale AlloteyInternational Institute for Global Health, United Nations University, Hospital Canselor Tuanku Muhriz UKM, Bandar Tun Razak, Cheras, Kuala Lumpur, Malaysia.
Nina SchwalbeInternational Institute for Global Health, United Nations University, Hospital Canselor Tuanku Muhriz UKM, Bandar Tun Razak, Cheras, Kuala Lumpur, Malaysia; Heilbrunn Department of Population and Family Health, Mailman School of Public Health, New York, NY 10032, USA; Spark Street Advisors, New York, NY, USA. Electronic address: nschwalbe@ssc.nyc.
United Nations University-International Institute for Global Health · MYGhana Health Service · GHInstitute for Family Health · USUniversité de Montréal · CAWorld Health Organization Regional Office for Africa · CG

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HumansImmunizationPandemicsVaccination

Identifiers

PMID35780789
PMCPMC9246460
OpenAlexW4283762280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.